Antithrombin: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
== Relevance == | == Relevance == | ||
AT activity is enhanced upon <scene name='46/466527/Cv/ | AT activity is enhanced upon <scene name='46/466527/Cv/3'>binding to the anticoagulant drug heparin</scene>. | ||
==Structural highlights== | ==Structural highlights== |
Revision as of 12:23, 8 December 2015
FunctionAntithrombin (AT) inactivates several enzymes of the coagulation cycle. AT is relatively inactive until it binds the heparan sidechains of the microvasculature.[1] ▪ α-AT contains 4 occupied glycosylation sites and is found in blood palsma. DiseaseAT deficiency diseases are: Acquired AT deficiency and Inherited AT deficiency. AT deficiency is involved in thrombosis and pulmonary embolism. RelevanceAT activity is enhanced upon . Structural highlightsThe binding of AT to the heparans or the heparin drug is to a core pentasaccharide. The binding induces conformational change of AT. |
|
3D structures of antithrombin3D structures of antithrombin
Updated on 08-December-2015
ReferencesReferences
- ↑ Li W, Johnson DJ, Esmon CT, Huntington JA. Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol. 2004 Sep;11(9):857-62. Epub 2004 Aug 15. PMID:15311269 doi:10.1038/nsmb811